Kalmar Investments’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
CBOA
Kalmar Investments's RMD Position: Q1 2017 in Review
Kalmar Investments reduced its ResMed (RMD) stake by 81% in Q1 2017, selling an estimated $21.3M and leaving 72,853 shares worth $5.24M. The position accounts for 1.18% of the portfolio, ranked #41.
Kalmar Investments first reported a position in RMD in Q2 2013 and has held it in 16 quarters since. The position peaked at $79.4M in Q1 2015. 375 funds tracked by Wall St. Rank hold RMD as of Q1 2017.
- Kalmar Investments held 72,853 shares of ResMed worth $5.24M as of Q1 2017.
- Kalmar Investments sold 307,860 ResMed shares in Q1 2017, an estimated $21.3M.
- ResMed made up 1.18% of Kalmar Investments's portfolio in Q1 2017, its #41 holding.
- Kalmar Investments first reported a position in ResMed in Q2 2013 and has held it in 16 quarters since.
- Kalmar Investments's ResMed position peaked at $79.4M in Q1 2015.
- 375 funds tracked by Wall St. Rank held ResMed as of Q1 2017.
Based on Kalmar Investments's 13F filing for Q1 2017, filed 26 Apr 2017.